Shannon Standridge
Neurology with Special Qualifications in Child Neurology · Cincinnati, OHNPI 1922219922
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $55,480 of the $79,186 with a category attached, or 70.1%. 9 manufacturers reported payments, led by Acadia Pharmaceuticals Inc at 54.6% of the total. Among neurology with special qualifications in child neurology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 97 payments — averaging $816.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acadia Pharmaceuticals Inc$43K
- Greenwich Biosciences, Inc.$33K
- GW Research Limited$2K
- EMD Serono, Inc.$475
- SK Life Science, Inc.$346
- UCB, Inc.$211
- plus $209 from 3 others
Across 96 payments — averaging $7991.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Acadia Pharmaceuticals Inc$594K
- GW Research Limited$173K
What the payments were for
- Consulting fees$15,27519%
- Speaking & faculty fees$55,48070%
- Travel & lodging$6,3728%
- Food & beverage$2,0303%
- Education$290%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acadia Pharmaceuticals Inc | 35 | $43,237 |
| Greenwich Biosciences, Inc. | 36 | $32,520 |
| GW Research Limited | 7 | $2,188 |
| EMD Serono, Inc. | 1 | $475 |
| SK Life Science, Inc. | 8 | $346 |
| UCB, Inc. | 6 | $211 |
| Mallinckrodt Enterprises LLC | 1 | $116 |
| Immedica Pharma US, Inc. | 1 | $55 |
| Jazz Pharmaceuticals Inc. | 2 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$79,186 in reported general payments places this provider in the 90th percentile of 113 neurology with special qualifications in child neurology providers in Ohio.
See all neurology with special qualifications in child neurology providers in Ohio →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BriviactBrivaracetam | 18 | $33,675 |
| NayzilamMidazolam | 13 | $18,635 |
| VimpatLacosamide | 11 | $11,780 |
| Rufinamide | 12 | $10,622 |
| Clobazam | 13 | $5,094 |
| Lacosamide | 33 | $3,351 |
| Oxcarbazepine | 14 | $2,597 |
| Divalproex Sodium | 17 | $1,399 |
| Divalproex Sodium ErDivalproex Sodium | 13 | $1,344 |
| LevocarnitineLevocarnitine (With Sugar) | 23 | $1,150 |
| Lamotrigine | 28 | $679 |
| Clonazepam | 52 | $642 |
| Lorazepam | 12 | $26 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| UCB, Inc.Briviact, Nayzilam, Vimpat | $211 | $64,09042 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 113 neurology with special qualifications in child neurology providers in Ohio.
Other neurology with special qualifications in child neurology in Cincinnati
- Hope O'BrienCincinnati$525K
- Tracy GlauserCincinnati$130K
- Cuixia TianCincinnati$91K
- Darcy KruegerCincinnati$45K
- Andrew HersheyCincinnati$36K
- Susan FongCincinnati$32K
- Donald GilbertCincinnati$19K
- Marielle SamahaCincinnati$12K
- Gewalin AungaroonCincinnati$8K
- Steven WuCincinnati$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.